Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Spark Therapeutics faces a grilling as FDA ponders a pioneering OK for gene therapy
Spark Therapeutics faces a grilling as FDA ponders a pioneering OK for gene therapy
Spark Therapeutics faces a grilling as FDA ponders a pioneering OK for gene therapy
Submitted by
admin
on October 10, 2017 - 9:38am
Source:
Endpoints
News Tags:
Spark Therapeutics
FDA
gene therapy
Luxturna
retinal dystrophies
Headline:
Spark Therapeutics faces a grilling as FDA ponders a pioneering OK for gene therapy
Do Not Allow Advertisers to Use My Personal information
